Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
16.46
-0.46 (-2.72%)
At close: Apr 28, 2026, 4:00 PM EDT
16.42
-0.04 (-0.24%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Pharming Group Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Pharming Group stock have an average target of 38.33, with a low estimate of 37 and a high estimate of 41. The average target predicts an increase of 132.87% from the current stock price of 16.46.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pharming Group stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +124.79% | Apr 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +124.79% | Mar 24, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $42 → $41 | Buy | Reiterates | $42 → $41 | +149.09% | Mar 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +124.79% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +124.79% | Mar 20, 2025 |
Financial Forecast
Revenue This Year
413.89M
from 376.13M
Increased by 10.04%
Revenue Next Year
424.26M
from 413.89M
Increased by 2.51%
EPS This Year
0.04
from 0.00
Increased by 786.02%
EPS Next Year
0.05
from 0.04
Increased by 27.91%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 477.0M | 557.8M | |||
| Avg | 413.9M | 424.3M | |||
| Low | 333.7M | 257.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 26.8% | 34.8% | |||
| Avg | 10.0% | 2.5% | |||
| Low | -11.3% | -37.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 0.05 | 0.09 | ||
| Avg | 0.04 | 0.05 | ||
| Low | 0.01 | -0.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 1,265.3% | 143.0% | ||
| Avg | 786.0% | 27.9% | ||
| Low | 145.1% | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.